In order to produce and maintain high quality in all products, A.D.A.M.has continually supported and refined its editorial process. An overview of this process is provided below. The process covers all content A.D.A.M. develops textually as well as its award-winning visuals.

In addition, A.D.A.M. provides information regarding the following:

  • A.D.A.M. Editorial team
  • A.D.A.M. Medical Illustrations team
  • A.D.A.M. Medical Review Board
  • Third party content
  • Health Management Tools
  • Sourcing
  • Claims of therapeutic benefit
  • Advertising, sponsorship, & promotions policy
  • Conflict of interest policy
  • Financial/business policy
  • Linking policy
  • Spy ware policy
  • Plain language policy
  • Editorial processes

Visual – A.D.A.M. has established, maintained, and expanded a unique catalog of illustrations and animations. Since the beginning of our company, A.D.A.M. has been known for high-quality visual content and was one of the first publishers to illustrate every structure in both the male and female bodies. As a result, we have been able to leverage our core visual assets into multiple levels of product distribution.

All visual content, including images, animations, and supporting text, are conceptualized, created, and reviewed by medical illustrators. All medical illustrators at A.D.A.M. have Master's degrees in medical illustration. Additionally, physicians and/or anatomical PhD's have reviewed this visual content for medical accuracy.

All illustrations and animations are reviewed by physicians every 2 years at minimum, according to set editorial schedules. Reviews can also be triggered by:

Physician notification of important advances: We receive ongoing feedback from our physicians about which visual content requires expedited review based on changes in medical practice.

Client and consumer feedback: External comments on our visual content are catalogued, evaluated, and considered in our review process. This feedback can trigger physician review of visual content.

The focus of the A.D.A.M. visual content is adjusted to convey information to different markets. Illustrations can be simplified for the consumer market. They can also show a higher level of detail for the professional and academic markets.

A.D.A.M. frequently uses illustrations to visually explain complex subjects, both to complement our health content and to enhance the educational value of our products. Through our internal illustration and animation style guide, we maintain visual consistency across all of products.

A.D.A.M.'s visual content is a living, growing asset that continues to evolve. We periodically review the aesthetic appeal of our visual assets based not only on client and consumer feedback but also on emerging changes in the market. For example, our recent investments include creating a library of high-definition (HD) videos of medical experts explaining health topics for the consumer and patient markets.

As a result of our dedication to aesthetic quality, A.D.A.M. artwork has received numerous awards throughout the years, including Best Interactive Site, Best Special Effects, and the Dr. Frank J. Netter Award.

Text – A.D.A.M. content is physician-reviewed and physician-updated, in collaboration with skilled consumer medical editors and writers. Most articles are reviewed by two, and sometimes three, physicians. A.D.A.M. places a reviewer's name, reviewer credentials, and review date at the bottom of all pages.

A.D.A.M.'s goal is to present evidence-based health information. Therefore, content in A.D.A.M. products is created by identifying the best available evidence from national guidelines, government agencies, recognized leading textbooks, and peer-reviewed literature. We ask our writers and reviewers to create content based both on the quality of the evidence and its applicability to everyday practice.

Our editorial standard is to objectively communicate the current standard of medical practice. All writers and reviewers must disclose any actual or potential conflict of interest. Disclosures must be made to the appropriate manager, director, or vice president at hiring or when such an interest develops. Supervisors review with company officers to decide if a conflict of interest does exist. If conflict of interest is determined, the writer or reviewer is reassigned or steps are taken to rectify the situation. Anything that might be perceived as a conflict of interest will be clearly disclosed on every relevant article.

A.D.A.M. has a robust process in place for keeping our extensive content up-to-date. At the beginning of every quarter, our Editorial Director identifies 500 to 600 articles that need to be reviewed and assigns them to physician reviewers. Articles are called up for review based on four criteria:

Set editorial schedules: All in-depth reports are reviewed at least every 12 months. All Encyclopedia content is reviewed at minimum every two years.

Physician notification of important advances: We receive ongoing feedback from our physicians about which articles require expedited review based on their reading of the recent medical literature and awareness of changes in medical practice.

Ongoing monitoring: Our Editors and Medical Director monitor peer-reviewed literature, announcements by government organizations, and new evidence-based guidelines published by major specialty societies for important changes in medical care that should not wait until the next scheduled review.

Client and consumer feedback: External comments on our content are catalogued, evaluated, and considered in our review process. This feedback can trigger an article review. The feedback is given to the physician to use while reviewing the article.

Our proprietary in-house content management system tracks articles to ensure that these editorial schedules are met. Every change a physician proposes is reviewed by a Senior Editor. The editor may propose more consumer-friendly wording and return these suggestions to the physician for consideration and approval. Our content management system handles the workflow. An article update is approved and sent to the next stage when both the editor and physician mutually agree that the update is both medically sound and consumer friendly.

Once an article is updated in English, it is sent into a workflow that manages the Spanish translation process (certain products only). Once both English and Spanish have been updated, they are published together and made available to clients.

The general flow of the editorial process is provided below. The process is divided into 5 steps.

Step 1 – Content Development

In Step 1, medical writers, clinical writers, or medical illustrators develop content. Previously published content is tagged for review and is internally reviewed for any additions or deletions. Additionally, since A.D.A.M. has built its reputation on the outstanding quality of its visual content, textual content is reviewed to add new or appropriate compelling visual content. Acquired content, depending on the source, may enter the editorial process at this stage.

Step 2 – Content Review

In Step 2, members of the Medical Review Board (MRB) and/or physicians from our external partner, VeriMed Healthcare Network, may review content. Both the MRB and the VeriMed Healthcare Network consist of board-certified physicians, who are specialists in their field. Physicians write and review content in their specialty areas; ensure content is up-to-date with the most recent treatment guidelines and practices, important studies, breakthrough drugs, and drug warnings; and help the A.D.A.M. Editorial Team perform consistency checks across products. Important medical advances to certain content and article reviews triggered by client and consumer feedback may enter the editorial process at this stage. All content reviews are approved by the Medical Director at this stage.

Step 3 – Content Editorial

In Step 3, A.D.A.M.'s Editorial Team reviews the content following medical review for grammar, style, and consistency. The Editorial Team reviews all content, both textual and visual. A content quality assurance check is also performed. Acquired content, which has demonstrated adherence to the criteria of the MRB and A.D.A.M. editorial standards, may enter the editorial process at this stage.

Step 4 – Content Production

In Step 4, the content is indexed, stored in our proprietary in-house content management system, coded, and tagged for presentation. Associated Spanish content is translated and stored in our content management system at this time. A technical and content quality assurance check is also performed during this step.

Step 5 – Content Publication

In Step 5, content is provided to customers. Licensees integrate the A.D.A.M. content with their internet web sites and provide feedback to the editorial process in the form of customer queries and inquiries. Content is regularly updated. In most cases, the update cycle is quarterly. Once a customer receives an update, they have a contractual obligation to implement the updated content on their site.

Editorial Policy

A.D.A.M., Inc. has served millions of consumers around the world for over 16 years with award-winning, health information and products that have literally changed the way people look at their bodies, understand their health and wellness, and learn the science of medicine. As A.D.A.M. continues to grow, we are constantly creating new content internally while acquiring high quality assets externally.

A.D.A.M. has made a public commitment to editorial excellence. We have been deeply involved in shaping the policies of Hi-Ethics, the URAC American Accreditation HealthCare Commission (URAC) Health Web Site Accreditation Program, and the Center for Information Therapy, three cooperating organizations that have been at the forefront of the industry movement to ensure quality of health information on the internet.

A.D.A.M. is a founding member of Hi-Ethics, a nonprofit organization that was established to address concerns over the security, quality, and ethical standards of consumer health information on the internet. Today, Hi-Ethics has become part of the Center for Information Therapy.

A.D.A.M. was among the first group of companies to receive URAC accreditation for health information, and has maintained its accreditation since that time. The URAC accreditation seal indicates that A.D.A.M.'s consumer health products are in compliance with 49 rigorous standards of quality and accountability, verified in an independent audit by URAC (www.urac.org). URAC performs this audit every 2 years.

Evidence-Based Content

A.D.A.M.'s goal is to present evidence-based health information. Therefore, content in A.D.A.M. products is created by identifying the best available evidence from national guidelines, government agencies, and peer-reviewed literature, and then asking our writers and reviewers to create content based both on the quality of the evidence and its applicability to everyday practice.

Our physician reviewers are instructed to use the best, evidence-based sources, using the following hierarchy. Source references are added to products during regularly scheduled reviews and can be found in the References section near the bottom of each article. A.D.A.M. maintains at least a 2-year review schedule for our health content.

1st – Level of Evidence

- National guidelines and consensus statements from government-sponsored agencies. Examples include:

The United States Preventive Services Task Force (USPSTF)

National Institutes of Health (NIH) Clinical Statements

Agency for Health Care Research and Quality (AHRQ) Clinical Statements

Centers for Disease Control and Prevention (CDC)

National Cancer Institute (NCI)

Advisory Committee on Immunization Practices (ACIP)

- Clinical position papers and guidelines from highly reputed professional societies, when their statements are based upon referenced clinical evidence and their recommendations either describe or explicitly state the level of evidence for any recommendations. Examples include:

American College of Physicians (ACP)

American College of Cardiology (ACC)

American College of Chest Physicians

American Academy of Pediatrics

American Academy of Neurology

- Technology assessments

- Randomized controlled trials and systematic reviews or meta-analyses, published either by organizations such as the Cochrane Database of Systematic Reviews or in peer-reviewed literature

2nd – Level of Evidence

- Current editions of recognized leading textbooks in the field

- Review articles and selected controlled trials published in major journals such as the New England Journal of Medicine, JAMA, or Lancet, as well as in major specialty journals such as Circulation, Neurology, and Pediatrics.

3rd – Level of Evidence

- Consists primarily of consensus medical opinion.

Using Evidence in Consumer-Oriented Writing

A.D.A.M. content is physician-reviewed and physician-updated, in collaboration with skilled consumer medical editors and writers. Most articles are reviewed by two, and sometimes three, physicians. Reviewers receive a style guide to help them write with the A.D.A.M. voice.

A.D.A.M.'s content is written in plain language, for lay readers. The information is designed to be easily accessible, visually pleasing, and informative. We strive for a 6th to 7th grade reading level, logical organization, short sentences and common everyday words, and design features that make the content easy to read, understand, and use.

Some of our more in-depth content is written at a higher reading level for readers who wish to pursue a more advanced study of health topics. To continue the tradition of editorial excellence, A.D.A.M. has established an editorial process that is facilitated by a Content Review Board.

To learn more ABOUT US's Editorial Process, a concise description can be found here.

A.D.A.M. Medical Review Board

A.D.A.M. has made a strategic decision to work with outside, independent reviewers. A.D.A.M.'s Medical Review Board includes more than a dozen physicians who work closely with A.D.A.M. on a daily basis to update and expand A.D.A.M.'s vast consumer information database. These physicians:

  • Write and review content in their specialty areas
  • Ensure content is up-to-date with the most recent treatment guidelines and practices, important studies, breakthrough drugs, and drug warnings
  • Help the A.D.A.M. Editorial Team perform consistency checks across products

Physicians on the A.D.A.M. Medical Review Board are affiliated with leading institutions across the country, including top hospitals as ranked by U.S. News and World Report. Physicians are chosen to review or write medical content only in the clinical areas in which they have been formally trained and actively practice. They are board certified for that specialty, where applicable.

Members of the A.D.A.M. Medical Review Board are listed below.

ALLERGY AND IMMUNOLOGY

Stuart I. Henochowicz, MD, FACP, Associate Clinical Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, Georgetown University Medical School.

BARIATRIC SURGERY

Ann Rogers, MD, Associate Professor of Surgery; Director, Penn State Surgical Weight Loss Program, Penn State Milton S. Hershey Medical Center.

Alex Nagle, MD, Director of Bariatric Surgery, Northwestern Memorial Hospital, Assistant Professor of Surgery, Division of Gastrointestinal & Oncologic Surgery, Northwestern University Feinberg School of Medicine.

CARDIOLOGY

Michael A. Chen, MD, PhD, Assistant Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, Washington.

DERMATOLOGY

Roy Colven, MD, Dermatologist, Assosciate Professor of Medicine, University of Washington Medical School, Seattle, Washington.

EMERGENCY MEDICINE

Jacob L. Heller, MD, Emergency Medicine, Virginia Mason Medical Center, Seattle, Washington, Clinic.

FAMILY PRACTICE

Linda Vorvick, MD, Seattle Site Coordinator, Pathophysiology, MEDEX Northwest Division of Physician Assistant Studies, University of Washington School of Medicine.

GASTROENTEROLOGY

George F. Longstreth, MD, Department of Gastroenterology, Kaiser Permanente Medical Care Program, San Diego, California.

HEMATOLOGY

Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital.

INFECTIOUS DISEASE

Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital.

INTERNAL MEDICINE

David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine.

Harvey Simon, MD, Associate Professor of Medicine, Harvard Medical School, Physician, Massachusetts General Hospital.

NEPHROLOGY

Herbert Y. Lin, MD, Nephrologist, Massachussets General Hospital; Associate Professor of Medicine, Harvard Medical School

NEUROLOGY

Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital.

Dee Silver, MD, Neurologist, Coastal Neurological Medical Group, Inc., La Jolla, California.

OBSTETRICS/GYNOCOLOGY

Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Redmond, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine.

OPHTHALMOLOGY

Franklin W. Lusby, MD, Ophthalmologist, Lusby Vision Institute, La Jolla, California.

ORTHOPEDICS

C. Benjamin Ma, MD, Assistant Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery.

OTOLARYNGOLOGY

Seth Schwartz, MD, MPH, Otolaryngologist, Virginia Mason Medical Center, Seattle, Washington.

PEDIATRICS

Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine.

Jennifer K. Mannheim, ARNP, Medical Staff, Department of Psychiatry and Behaviorial Health, Seattle Children's Hospital.

PULMONOLOGY

Denis Hadjiliadis, MD,Assistant Professor of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania, Philadelphia, PA.

PSYCHIATRY

Michelle Banger Merrill, MD, Instructor in Clinical Psychiatry, Department of Psychiatry, Columbia University of Medical Center, New York, NY.

David B. Merrill, MD, Assistant Clinical Professor of Psychiatry, Department of Psychiatry, Columbia University Medical Center, New York, NY.

Fred K. Berger, MD, Addiction and Forensic Psychiatry, Scripps Memorial Hospital, La Jolla, California.

SURGERY

Debra G. Wechter, MD, FACS, General Surgery practice specialising in breast cancer, Virginia Mason Medical Center, Seattle, Washington.

UROLOGY

Scott Miller, MD, Urologist in private practice, Atlanta, Georgia.

Louis S. Liou, MD, PhD, Assistant Professor of Urology, Department of Surgery, Boston University School of Medicine.

VeriMed Healthcare Network

A.D.A.M. also uses the VeriMed Healthcare Network to review and update many of its articles. VeriMed is a comprehensive group of over 550 practicing, board-certified physician writers and educators representing all medical subspecialties. VeriMed doctors are affiliated with leading institutions across the country, including the top hospitals as ranked by U.S. News and World Report.

A.D.A.M. works closely with VeriMed on a daily basis. VeriMed physicians are chosen to review or write medical content only in the clinical areas in which they have been formally trained and actively practice. They are board certified or board eligible for that specialty, where applicable. Some of these physician reviewers are listed below.

Adolescent Medicine

John Goldenring, MD, MPH, JD, Pediatrics, Sharp Rees-Stealy Medical Group, San Diego, CA.

Allergy and Immunology

Paula J. Busse, MD, Assistant Professor of Medicine, Division of Clinical Immunology, Mount Sinai School of Medicine, New York, NY.

Neil J. Gonter, MD, Assistant Professor of Medicine, Columbia University, NY and private practice specializing in Rheumatology at Rheumatology Associates of North Jersey, Teaneck, NJ.

Cardiology

Glenn Gandelman, MD, MPH, FACC, Assistant Clinical Professor of Medicine at New York Medical College; Private Practice specializing in Cardiovascular Disease in Greenwich, CT.

Steven Kang, MD, Division of Cardiac Pacing and Electrophysiology, East Bay Arrhythmia, Cardiovascular Consultants Medical Group, Oakland, CA.

Dentistry

Michael Kapner, DDS, General and Cosmetic Dentistry, Scarsdale, NY.

Dermatology

Kevin Berman, MD, PhD, Atlanta Center for Dermatologic Disease, Atlanta, GA.

Diabetes

Shehzad Topiwala, MD, Consultant Endocrinologist, Vera Endocrine Associates, Daytona Beach, FL.

Nancy J. Rennert, MD, Chief of Endocrinology & Diabetes, Norwalk Hospital, Associate Clinical Professor of Medicine, Yale University School of Medicine, New Haven, CT.

Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology & Metabolism, Johns Hopkins School of Medicine Lutherville, MD.

Diagnostic Radiology

Javed Quareshi, MD, Diplomate, American Board of Radiology, Victoria Radiology Associates, Victoria, TX.

Kenneth (Ken) Levin, MD, Private practice specializing in Radiology and Nuclear Medicine, Allentown, PA.

Diet & Nutrition

William McGee, MD, MHA, Assistant Professor of Medicine and Surgery, Tufts University School of Medicine, Boston, MA, and Chairman, Nutrition Committee, Baystate Medical Center, Springfield, MA.

Diagnostic Radiology

Javed Quareshi, MD, Diplomate, American Board of Radiology, Victoria Radiology Associates, Victoria, TX.

Kenneth (Ken) Levin, MD, Private practice specializing in Radiology and Nuclear Medicine, Allentown, PA.

Emergency Medicine

Eric Perez, MD, St. Luke's / Roosevelt Hospital Center, NY, NY, and Pegasus Emergency Group (Meadowlands and Hunterdon Medical Centers), NJ.

Endocrinology and Metabolism

Robert Hurd, MD, Department of Biology, College of Arts and Sciences, Xavier University, Cincinnati, OH.

Gastroenterology

Todd Eisner, MD, Private practice specializing in Gastroenterology, Boca Raton, FL. Clinical Instructor, Florida Atlantic University School of Medicine.

General Surgery

John A. Daller, MD, PhD, Department of Surgery, Crozer-Chester Medical Center, Chester, PA.

David A. Lickstein, MD, FACS, Specializing in cosmetic and reconstructive plastic surgery, Palm Beach Gardens, FL.

Matthew M. Cooper, MD, FACS, Medical Director, Cardiovascular Surgery, HealthEast Care System, St. Paul, MN.

Genetics

Chad Haldeman-Englert, MD, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.

Gerontology

Sandra W. Cohen, MD Private Practice specializing in geriatrics, Brooklyn, NY.

Hematology & Oncology

Mark Levin, MD, Hematologist and Oncologist, Newark, NJ.

odd Gersten, MD, Hematology/Oncology, Palm Beach Cancer Institute, West Palm Beach, FL.

Infectious Disease

Daniel Levy, MD, Infectious Disease, Maryland Family Care, Lutherville, MD.

Internal Medicine

Jeffrey Heit, MD, Hospitalist Director for Cancer Treatment Centers of America – Eastern Regional Medical Center, Philadelphia, PA.

Chad Haldeman-Englert, MD, FACMG, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC.

Naturopathy

Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ.

Neurology

Luc Jasmin, MD, PhD, FRCS (C), FACS, Department of Neurosurgery at Cedars-Sinai Medical Center, Los Angeles CA; Department of Surgery at Los Robles Hospital, Thousand Oaks CA; Department of Surgery at Ashland Community Hospital, Ashland OR; Department of Surgery at Cheyenne Regional Medical Center, Cheyenne WY; Department of Anatomy at UCSF, San Francisco CA.

Obstetrics & Gynocology

Irina Burd, MD, PhD, Assistant Professor of OB/GYN and Neurology at Johns Hopkins University School of Medicine, Baltimore, MD.

Melanie N. Smith, MD, PhD, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.

Opthalmology

Paul B. Griggs, MD, Department of Ophthalmology, Virginia Mason Medical Center, Seattle, WA.

Orthopedic Surgery

Andrew W. Piasecki, MD, Camden Bone and Joint, LLC, Orthopaedic Surgery/Sports Medicine, Camden, SC.

Otolaryngology

Ashutosh Kacker, MD, BS, Associate Professor of Otolaryngology, Weill Cornell Medical College, and Associate Attending Otolaryngologist, New York-Presbyterian Hospital, New York, NY.

Pediatrics

Robert A. Cowles, MD, Associate Professor of Surgery, Yale University School of Medicine, New Haven, CT.

Donald Accetta, MD, MPH, President, Allergy & Asthma Care, PC, Taunton, MA.

Kimberly G. Lee, MD, MSc, IBCLC, Associate Professor of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, SC.

Psychiatry

Christos Ballas, MD, Attending Psychiatrist, Hospital of the University of Pennsylvania, Philadelphia, PA.

Pulmonology

Allen J. Blaivas, DO, Clinical Assistant Professor of Medicine UMDNJ-NJMS, Attending Physician in the Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Veteran Affairs, VA New Jersey Health Care System, East Orange, NJ.

Radiology

Stuart Bentley-Hibbert, MD, PhD, Department of Radiology, Weill Cornell Medical Center, New York, NY.

Rheumatology

Ariel D. Teitel, MD, MBA, Clinical Associate Professor of Medicine, NYU Langone Medical Center.

Surgery

Robert A. Cowles, MD, Assistant Professor of Surgery, Columbia University College of Physicians and Surgeons, New York, NY.

Urology

Marc A, Greenstein, DO, FACOS, Urologist, Somerset Medical Center in Somerville, NJ.

A.D.A.M. Editorial Team

A.D.A.M. uses primarily internal personnel to write, review, and update its articles. All new and updated articles are then reviewed and approved by a member of our medical review board with expertise in the subject area. Internal personnel have a minimum of 5 years of experience writing and editing health content. Articles reviewed by this team of professionals are referenced using "A.D.A.M. Editorial Team: David Zieve, MD, MHA, Isla Ogilvie, PhD," and are documented as such in the "Reviewed by" section of relevant articles. Members of this team are listed below.

David Zieve, M.D., M.H.A., Medical Director

Dr. Zieve joined A.D.A.M. to set new industry standards for evidence-based health content. Prior to joining A.D.A.M., Dr. Zieve served as editor and product manager at Milliman Care Guidelines. Milliman is considered the industry standard for independently developed and produced evidence-based clinical guidelines used in a variety of web-based case management applications in hospitals, insurance companies, and case management agencies.

Isla Ogilvie, PhD, Strategic Content Director

Isla has an extensive background in medical writing and research whose work has been published in high impact, peer-reviewed medical journals. Prior to pursuing a career in medical writing, Ms. Ogilvie worked as a post-doctoral fellow at the Montreal Neurological Institute at McGill University, and researched the use of bioinformatic and biochemical approaches to identify mitochondrial defects responsible for progressive encephalopathy. Isla has been very instrumental in designing and editing successful programs and product launch training material for major pharmaceutical customers globally.

Internal editorial team

A.D.A.M.'s editorial team members have a minimum of 5 to 10 years in the health content industry. Some members of the writing team have clinical backgrounds. Their work is carefully scrutinized for medical accuracy, adherence to our centrist editorial voice, and patient and consumer friendliness. Editors receive ongoing evaluation, feedback, and encouragement from staff physicians and senior editors at A.D.A.M.

A.D.A.M. Medical Illustration Team

Our team of physicians also reviews all illustrations, animations, and supporting text. Reviewer names are documented as such in the “Reviewed by” section of the image page. A.D.A.M. uses professionally trained, master degreed medical illustrators to create and update visual content, including images, animations and supporting text, in consultation with physician reviewers.

A.D.A.M. uses professionally trained, master degreed medical illustrators to review and update visual content, including images, animations, and supporting text. Articles reviewed by this team of professionals are sourced using “A.D.A.M. Medical Illustration Team.”

Dan Johnson, M.S.M.I., Visual Asset Manager

Mr. Johnson has played key roles in product development since 1992. Dan has been instrumental in creating the look and feel of A.D.A.M.’s award-winning visual assets, including 2D image and animation content development, audio and video capture and post-production as well as medical illustration and animation art direction. His expertise has enabled A.D.A.M. to become and sustain a leadership role in providing high quality content to our clients, and ensure consumers and patients can understand complex medical topics. Dan completed his Masters of Science degree in Medical Illustration from the Medical College of Georgia in 1992.

Third Party Content

A.D.A.M. licenses/resells third party content. This content may or may not contain all information normally included in our articles, such as the specific reviewer name. If the reviewer name is absent, the source of the content is recognized as the institution that produced and/or reviewed the content. If A.D.A.M. has not provided the specific reviewer information from the third party vendor, A.D.A.M. cannot display the specific reviewer information with the article, only the institution name.

A.D.A.M. continues to review “best of breed” content providers. Availability of reviewer information is one of the criterion by which we judge third party content. As vendors are found and reviewed, A.D.A.M. reserves the right to add, replace, or remove third party content from our licensed product line.

Health Management Tools

A.D.A.M. uses internal personnel to write and update its health management tools, including health risk assessments (HRAs), Decision Assists (DAs), and wellness tools. Information in these tools is written in plain language and is drawn from the medical evidence and major clinical guidelines as documented in the references section. References are provided for each individual tool. Updates of these tools are documented as such in the “Reviewed by” section of the article. All tools are reviewed and approved by two people every 2 years, including a physician.

Advertising, Sponsorship & Promotions Policy

The following guidelines have been established by A.D.A.M., Inc. to govern advertising and sponsorship. For these purposes, “advertising” includes banner, contextual advertising, sponsored content, and/or promotions. “Sponsorship” includes all third party entities that create, promote, and/or distribute products and services. These regulations govern issues such as acceptance or denial of advertisements and or sponsorship by A.D.A.M., Inc. This policy may be modified at any time using A.D.A.M.’s sole discretion. If a modification occurs, A.D.A.M. will post a revised policy to the www.adam.com site.

A. A.D.A.M. does not accept advertising from outside parties to be displayed either on the www.adam.com web site, the demonstration web site, the online store located on the www.adam.com web site, or in the A.D.A.M. licensed content.

B. A.D.A.M. does not place advertisements in our content, nor do we generate any revenue from advertising or sponsorships. Clients who license our content may place advertising on the individual content pages, and may use words, design, or placement to differentiate this from their A.D.A.M. licensed content. The client has the ability to decide how to differentiate between A.D.A.M. licensed content and sponsored content.

C. A.D.A.M. has sole discretion for determining the types of advertising that will be accepted and displayed on the www.adam.com, and under no circumstances shall A.D.A.M.’s acceptance of any advertisement be considered an endorsement of the product(s) and/or service(s) advertised or for the company that manufactures, distributes, or promotes such product(s) or service(s).

D. A.D.A.M. retains the exclusive right to determine the way in which all search results for specific information by topic, keyword, or code are displayed on the www.adam.com web site or in A.D.A.M. licensed content. A.D.A.M. search results are not influenced based on monetary incentives provided by any advertisers or sponsors.

A.D.A.M. does not license or display “sponsored” content on the www.adam.com web site or license “sponsored” content to our clients. All content found on our web site or licensed to our clients has been created by, provided by, or influenced by either A.D.A.M. personnel or consulting professionals hired through our preferred vendors, who have a demonstrated ability to track, review schedules, article versions, and ongoing feedback on specific information. Vendors must also have safeguards against editorial conflicts of interest.

A.D.A.M. will not contact you to promote goods and services. A.D.A.M. will contact you only if you have selected “Yes” from the “Would you like to receive future email updates from A.D.A.M.” checkbox found in our online forms or requested sales information through our sales contact form.

Conflict of Interest Policy

All Medical Review Board physicians working on an A.D.A.M. project are required to disclose conflict-of-interest affiliations with any organization, pharmaceutical company, or medical device company when signing a consulting agreement to work with A.D.A.M. All physicians must also disclose any conflict-of-interest affiliations when they agree to an assignment.

A.D.A.M.’s Medical Director evaluates any potential conflict of interest disclosed by a physician, and makes a decision whether or not to continue using the physician. If conflict of interest is determined, the physician will be reassigned or steps will be taken to rectify the situation.

Conflict-of-interest affiliations can include:

Funding: Research support (including grants, salaries, equipment, supplies, and other expenses) by organizations, pharmaceutical companies, or medical device companies that may gain or lose financially through their work as a consumer health reviewer.

Employment: Recent or current engagement in a research project or anticipated employment by any organization, pharmaceutical company, or medical device company that may gain or lose financially through their work as a consumer health reviewer.

Personal financial interests: Stocks, shares, consultation fees, or other forms of payment from any organization, pharmaceutical company, or medical device company that may gain or lose financially through their work as a consumer health reviewer; and patents or patent applications that may be affected by their work as a consumer health reviewer.

A.D.A.M.’s Editorial Team members must disclose all financial and/or other interests they may have in medical, medical device, biotech, drug, or other companies that have a vested interest and/or influence in health care. Disclosures must be made to the appropriate manager, director, or vice president at hiring or when said interest develops. Supervisors will review with company officers to decide if there is a conflict of interest. If conflict of interest is determined, the staff member will be reassigned or steps will be taken to rectify the situation.

A.D.A.M. has no conflicts of interest in editorial decisions. Our review partner, VeriMed, asks their professionals about potential conflicts of interest and discloses any potential conflicts of interest to A.D.A.M. To date, no reviewers have had any conflicts of interest. As most of the physicians VeriMed uses are in fellowships and at the peak of their academic training, they tend not to be at the point of their careers where they have developed consulting agreements with pharmaceutical and/or device companies.

A.D.A.M.’s editorial processes are completely independent of any client relationships, except when we develop custom content for specific clients. In these instances, the content does not, nor will it ever, contain any mention of URAC or display the seal.

Autonomy of Editorial Department

All A.D.A.M. Editorial and Visual Production staff members must disclose conflict-of-interest affiliations with any organization, pharmaceutical company, or medical device company. Disclosures must be made to the appropriate manager, director, or vice president at hiring or when such an interest develops. Supervisors review with company officers to decide if a conflict of interest does exist. If conflict of interest is determined, the staff member is reassigned or steps are taken to rectify the situation.

All Medical Review Board physicians working on an A.D.A.M. project are required to disclose conflict-of-interest affiliations with any organization, pharmaceutical company, or medical device company signing a consulting agreement to work with A.D.A.M. All physicians must also disclose any conflict-of-interest affiliations when they agree to an assignment.

A.D.A.M.’s Medical Director evaluates any potential conflict of interest disclosed by a physician and makes a decision on whether or not to continue using the physician’s services. If conflict of interest is determined, the physician is reassigned or steps are taken to rectify the situation.

A.D.A.M. has no conflicts of interest in editorial decisions. Our review partner, VeriMed Healthcare Network, asks their professionals about potential conflicts of interest and discloses any potential conflicts of interest to A.D.A.M. To date, no reviewers have had any conflicts of interest. As most of the physicians VeriMed uses are in fellowships and at the peak of their academic training, they tend not to be at the point of their careers where they have developed consulting agreements with pharmaceutical or device companies.

A.D.A.M.’s editorial processes are completely independent of any client relationships, except when we develop custom content for specific clients. In these instances, the content does not, nor will it ever, contain any mention of URAC or display the seal.

Financial / Business Policy

A.D.A.M. has no financial and/or business relationship based on linking to third party web sites. A.D.A.M. selects its content partners after a thorough analysis of competing vendors. Only vendors with high editorial standards are considered, such as Reuters News, HealthDay News, Thomson, and Lexicomp. A final decision is made based on vendors that use qualified staff and have reliable procedures in place for developing and updating their own content. This includes a demonstrated ability to track review schedules, article versions, and ongoing feedback on specific information. Vendors must also have safeguards against editorial conflicts of interest. For more information, please read our linking policy below.

A.D.A.M. is owned by Ebix, Inc. (EBIX-NASDAQ), a publicly traded company. Our content is not supported or endorsed by any individual, group, company, or industry that could influence the content.

The web site owner is:
Ebix, Inc.
10 10th Street NE
Suite 500
Atlanta, Georgia 30309

Linking Policy

A.D.A.M. content links only to a select number of high quality web sites. These sites must have the following criteria:

Non-profit organization
Mission and goals clearly explained on site
Focuses on a specific disease or health topic
Provides in-depth information that is easy to find on the site
Content is developed by qualified staff, including physician review, and kept up to date.

These sites do not have financial or business relationships with A.D.A.M.

A content user can report the existence of any broken link through A.D.A.M.'s user feedback mechanism. All reported broken links are entered into the user feedback tracking mechanism, fixed, and the status of the link is then reported back to the user or client.

A.D.A.M. does not notify the user that selecting one of these linked sites may take them away from the host site, nor do we provide the information in a pop-up window. The decision of how to handle linked sites is left up to the individual client.

Spyware Policy

Spyware is software that is installed deceptively to gather information about you without your knowledge. This can include centrally recording your personal internet usage, monitoring your keyboard strokes, or capturing personal information.

Web pages and content provided by A.D.A.M., Inc. contain NO spyware. A.D.A.M. does not condone the use of spyware nor support the distribution of spyware to others.

On occasion, A.D.A.M. uses “Session Cookies,” which are not considered “Spyware,” to enhance the usability and functionality of the A.D.A.M. web sites, in particular our Online Store. Information derived from “Session Cookies” is solely used by A.D.A.M., Versign, and our shipping vendors to move you through the forms needed to purchase, process, and ship a product, and not in any way distributed to any other third parties.

In addition, these cookies may be used to determine if the user has previously completed an online form, and populate these previous responses in the form. “Cookies” are solely used to enhance the user experience of the web site to the end user. In no way is the information contained in or derived from the use of “Cookies” used outside the scope of its intended purpose.

False or Misleading Claims Policy

A.D.A.M. does not place advertisements in our content, nor do we generate any revenue from advertising or sponsorships. Clients who license our content may place advertising on the individual content pages, and may use words, design, or placement to differentiate this from their A.D.A.M. licensed content. The client has the ability to decide how to differentiate between A.D.A.M. licensed content and sponsored content.

A.D.A.M. has sole discretion for determining the types of advertising that will be accepted and displayed on the www.adam.com, and under no circumstances shall A.D.A.M.’s acceptance of any advertisement be considered an endorsement of the product(s) and/or service(s) advertised or for the company that manufactures, distributes, or promotes such product(s) or service(s).

Therefore, A.D.A.M. does not support false and/or misleading claims from advertisements or sponsors, nor does A.D.A.M. knowingly publish false and/or misleading claims.

A.D.A.M. does not support the promotion of ineffective or dangerous products. In fact, A.D.A.M. does not promote any medical products or service within our content.

A.D.A.M. has established rigorous editorial policies and procedures to ensure that clients receive best-in-class health information. Our policies and procedures are designed to create and maintain content that is:

Based on evidence from the most up-to-date, highest-quality sources
Easy for consumers to read and understand
Consistent across our product line
Free from commercial bias
Consistent with best practice, as performed by high-quality providers in the community

All physician reviewers will not knowingly introduce false or misleading claims into A.D.A.M. content. In addition, all A.D.A.M. editorial and visual production staff will not knowingly introduce false or misleading claims into A.D.A.M. content.

All physician reviewers will not knowingly promote ineffective or dangerous products within A.D.A.M. content. In addition, all A.D.A.M. editorial and visual production staff will not knowingly promote ineffective or dangerous products within A.D.A.M. content.

If a false or misleading claim is determined, steps are taken to rectify the situation. The Editorial Director will follow up on client or consumer feedback indicating possible false or misleading claims in A.D.A.M. content by immediately sending the content for physician review.

The Strategic Content Director will follow up on client or consumer feedback indicating possible false or misleading claims, or the promotion of ineffective or dangerous products, in A.D.A.M. content by immediately sending the content for physician review.

The Medical Director and Strategic Content Director will make spot checks of reviews and published content for adherence to this policy. In the event of a possible false or misleading claim, or the promotion of ineffective or dangerous products, an article can be rejected by the Medical Director or Strategic Content Director and sent back to the editor or physician for another round of review and editing.

In the event information or content is identified and determined to be inaccurate or misleading, or the promotion of ineffective or dangerous products is identified, the Editorial Team immediately assigns the article to a physician reviewer with a "rush" deadline. The physician reviewer will log into the Content Management System (CMS), carefully review the article, make the appropriate change(s), and send it back to the Editorial Team for review as part of the review workflow. The Strategic Content Director will ensure that the content is now correct and meets or exceeds A.D.A.M. editorial standards, and will accept the change and push the content for Spanish translation (if there is a Spanish product equivalent). Once translated, reviewed, accepted by the Strategic Content Director one final time, the content is published and made available to our clients.

Once published, changed content is immediately available on the A.D.A.M. demonstration site and hosted client sites, and made available for download for our clients through TransADAM, our proprietary content distribution software. Once an identified issue is completed, the QOC committee will review the procedure to ensure this project was completed in a timely manner (usually within 2 to 3 days, including translation).

Last updated: 04/07/14

Recent News

A.D.A.M. OnDemand is the most comprehensive library of off-the-shelf medical eLearning programs for patients, students, health care professionals and the pharmaceutical industry.
READ MORE
A.D.A.M.'s recently launched its Vital Signs e-newsletter that includes a variety of articles about A.D.A.M., its solutions and the health care information industry. The quarterly Vital Signs...
READ MORE
This free Continuing Education (CE) webinar "Introduction to the Cardiovascular System and Decreasing Cardiac Readmissions" was presented by A.D.A.M.'s John Borowski...
READ MORE